Ann Oncol

1. ROS J, Matito J, Villacampa G, Comas R, et al
   Corrigendum to "Plasmatic BRAF-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with BRAF combinatorial treatments": [Annals of Oncology 34 (2023) 543-552].
   Ann Oncol. 2024 Aug 12:S0923-7534(23)00796-2. doi: 10.1016/j.annonc.2023.
   

   >> Share

   
   

   
   Ann Surg Oncol

2. REITZ ACW, Massarweh NN
   Preoperative Staging of Colon Cancer-Picking the Lesser of Two Evils.
   Ann Surg Oncol. 2024 Aug 16. doi: 10.1245/s10434-024-16052.
   

   >> Share

   
   

   
   BMC Cancer

3. HAGHI NAVAND A, Jalilian S, Ahmadi Angali K, Karimi Babaahmadi M, et al
   A new evaluation of the rearranged non-coding control region of JC virus in patients with colorectal cancer.
   BMC Cancer. 2024;24:1001.
   

   >> Share

   
   

   
   BMC Gastroenterol

4. TAN X, Zhang Y, Wu X, Fang Q, et al
   Mucinous histology is a negative predictor of neoadjuvant chemoradiotherapy for locally advanced rectal adenocarcinoma.
   BMC Gastroenterol. 2024;24:263.
   

   >> Share

   
   
5. NIU R, Jiang Y, Bi Z, Zhang H, et al
   The effect of cardiovascular disease on the perioperative period of radical surgery in elderly rectal cancer.
   BMC Gastroenterol. 2024;24:256.
   

   >> Share

   
   

   
   Br J Surg

6. BOZKURT E, Sijberden JP, Langella S, Cipriani F, et al
   Laparoscopic versus open right hepatectomy for colorectal liver metastases after portal vein embolization: international multicentre study.
   Br J Surg. 2024;111:znae181.
   

   >> Share

   
   

   
   Cancer Lett

7. LI M, Xie Y, Zhang J, Zhou X, et al
   Intratumoral injection of mRNA encoding survivin in combination with STAT3 inhibitor stattic enhances antitumor effects.
   Cancer Lett. 2024;598:217111.
   

   >> Share

   
   

   
   Cancer Res

8. SAHA S, Ghosh M, Li J, Wen A, et al
   Serine Depletion Promotes Antitumor Immunity by Activating Mitochondrial DNA-Mediated cGAS-STING Signaling.
   Cancer Res. 2024;84:2645-2659.
   

   >> Share

   
   

   
   Clin Cancer Res

9. DAS A, MacFarland SP, Meade J, Hansford JR, et al
   Clinical Updates and Surveillance Recommendations for DNA Replication Repair Deficiency Syndromes in Children and Young Adults.
   Clin Cancer Res. 2024;30:3378-3387.
   

   >> Share

   
   

   
   Dis Colon Rectum

10. OUCHI A, Iwahori Y, Suzuki K, Funahashi K, et al
    Artificial Intelligence Imaging Diagnosis Using Super-Resolution and Three-Dimensional Shape for Lymph Node Metastasis of Low Rectal Cancer: A Pilot Study From a Single Center.
    Dis Colon Rectum. 2024;67:1131-1138.
    

    >> Share

    
    

    
    Eur J Cancer

11. ZHANG P, Han Y, Cai Z, Cao D, et al
    Letter Re: A meta-analysis of efficacy and safety data from head-to-head first-line trials of epidermal growth factor receptor inhibitors versus bevacizumab in adult patients with RAS wild-type metastatic colorectal cancer by sidedness.
    Eur J Cancer. 2024 Aug 6:114266. doi: 10.1016/j.ejca.2024.114266.
    

    >> Share

    
    
12. BOTTA L, Capocaccia R, Bernasconi A, Rossi S, et al
    Estimating cure and risk of death from other causes of cancer patients: EUROCARE-6 data on head & neck, colorectal, and breast cancers.
    Eur J Cancer. 2024;208:114187.
    

    >> Share

    
    

    
    Eur J Surg Oncol

13. YANG X, Zhang Z, Bi X
    A nomogram for predicting colorectal cancer liver metastasis using circulating tumor cells from the first drainage vein.
    Eur J Surg Oncol. 2024;50:108579.
    

    >> Share

    
    

    
    Gut

14. DJORDJEVIC J, Cisneros Romero NS, Cascione L, Mele V, et al
    Direct toll-like receptor triggering in colorectal cancer-associated stromal cells elicits immunostimulatory properties leading to enhanced immune cell recruitment.
    Gut. 2024 Aug 8:gutjnl-2023-331759. doi: 10.1136/gutjnl-2023-331759.
    

    >> Share

    
    

    
    Int J Cancer

15. NAKATSUMI H, Komatsu Y, Harada K, Kawamoto Y, et al
    A multicenter, prospective, phase II trial of second-line aflibercept plus FOLFIRI in patients with metastatic colorectal cancer refractory to an anti-EGFR antibody: HGCSG1801.
    Int J Cancer. 2024 Aug 14. doi: 10.1002/ijc.35116.
    

    >> Share

    
    

    
    Int J Colorectal Dis

16. EDWARDS AL, Trang K, Tolstykh IV, Van Blarigan EL, et al
    Association between gastrointestinal symptoms and specialty care utilization among colon cancer survivors: a cohort study.
    Int J Colorectal Dis. 2024;39:130.
    

    >> Share

    
    
17. GRUNDLER E, Gerken M, Schatz S, Dittrich L, et al
    Transanal total mesorectal excision: short- and long-term results of four certified colorectal cancer centers in Germany.
    Int J Colorectal Dis. 2024;39:132.
    

    >> Share

    
    
18. JINGTAO Z, Bin W, Haoyu B, Hexin L, et al
    Prediction of postoperative complications following transanal total mesorectal excision in middle and low rectal cancer: development and internal validation of a clinical prediction model.
    Int J Colorectal Dis. 2024;39:133.
    

    >> Share

    
    
19. TANINO F, Yamashita K, Nagata S, Kuwai T, et al
    Vertical margin distance in T1 colorectal carcinoma resected by endoscopic submucosal dissection affects prognosis after additional surgery.
    Int J Colorectal Dis. 2024;39:134.
    

    >> Share

    
    

    
    Int J Oncol

20. LI H, Li D, Meng N
    [Retracted] Effects of RUNX3 mediated Notch signaling pathway on biological characteristics of colorectal cancer cells.
    Int J Oncol. 2024;65:91.
    

    >> Share

    
    

    
    J Am Coll Surg

21. HADDAD A, Odisio BC, Vauthey JN
    Invited Commentary: Should Patients with Colorectal Liver Metastases Undergo Ablation?
    J Am Coll Surg. 2024;239:285-287.
    

    >> Share

    
    
22. WELLS AB, Butano VW, Phillips MC, Mckillop IH, et al
    Outcomes after Surgical Microwave Ablation for the Treatment of Colorectal Liver Metastasis.
    J Am Coll Surg. 2024;239:276-285.
    

    >> Share

    
    

    
    Oncogene

23. GUPTA A, Avadhanula S, Bashyam MD
    Evaluation of the gene fusion landscape in early onset sporadic rectal cancer reveals association with chromatin architecture and genome stability.
    Oncogene. 2024;43:2449-2462.
    

    >> Share

    
    

    
    PLoS Comput Biol

24. GUNNARSSON EB, Kim S, Choi B, Schmid JK, et al
    Understanding patient-derived tumor organoid growth through an integrated imaging and mathematical modeling framework.
    PLoS Comput Biol. 2024;20:e1012256.
    

    >> Share

    
    

    
    PLoS Med

25. HELGESTAD ADL, Larsen MB, Njor S, Tranberg M, et al
    Increasing coverage in cervical and colorectal cancer screening by leveraging attendance at breast cancer screening: A cluster-randomised, crossover trial.
    PLoS Med. 2024;21:e1004431.
    

    >> Share

    
    

    
    PLoS One

26. WANG G, Hiramoto K, Ma N, Ohnishi S, et al
    Immunohistochemical analyses reveal FoxP3 expressions in spleen and colorectal cancer in mice treated with AOM/DSS, and their suppression by glycyrrhizin.
    PLoS One. 2024;19:e0307038.
    

    >> Share

    
    
27. NORTHROP-ALBRECHT EJ, Wu CW, Berger CK, Taylor WR, et al
    An investigation of plasma cell-free RNA for the detection of colorectal cancer: From transcriptome marker selection to targeted validation.
    PLoS One. 2024;19:e0308711.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

28. ZINK A, Obermeyer Z, Pierson E
    Race adjustments in clinical algorithms can help correct for racial disparities in data quality.
    Proc Natl Acad Sci U S A. 2024;121:e2402267121.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share